Safety monitoring begins during clinical development and continues throughout the lifecycle of a medicinal product. Pharmacovigilance brings together adverse event monitoring, safety data assessment, signal detection, risk evaluation, and ongoing surveillance to help understand how a medicine performs across different stages of its use. This continuous approach supports evidence-based safety decisions. Visit: https://curexbio.com/pharmacovigilance/